Acetic Acid

Acetic Acid

SCHEMBL25212436

CC(=O)[O-].CCCC[N+]1(C)CCCCC1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.53
LMNA P02545 4/20 0.51
APOBEC3A P31941 2/20 0.51
APOBEC3G Q9HC16 2/20 0.51
TSHR P16473 2/20 0.51
CYP3A4 P08684 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
KMT2A Q03164 2/20 0.47
CTDSP1 Q9GZU7 2/20 0.40
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
KDM4E B2RXH2 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL927376 0.98 BBOX1 (0.55) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL30329879 0.94 LMNA (0.54) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL29251899 0.93 LMNA (0.57) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL29252285 0.93 LMNA (0.57) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL29251720 0.93 LMNA (0.57) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL29251803 0.93 LMNA (0.57) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL15208533 0.93 BBOX1 (0.50) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL29251829 0.93 LMNA (0.57) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL29252554 0.93 LMNA (0.57) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR
Acetic Acid SCHEMBL30330953 0.92 LMNA (0.56) BBOX1LMNAAPOBEC3AAPOBEC3GTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617892-B2 Application of the ring-opening of uretdiones at low temperature and ambient atmosphere BASF SE (DE) 2026-05-05 US claimed
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BASF SE (DE) 2025-12-30 US claimed
US-20230348657-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-11-02 US claimed
US-20230323013-A1 APPLICATION OF THE RING-OPENING OF URETDIONES AT LOW TEMPERATURE AND AMBIENT ATMOSPHERE BASF SE (DE) 2023-10-12 US claimed
EP-4185627-A1 APPLICATION OF THE RING-OPENING OF URETDIONES AT LOW TEMPERATURE AND AMBIENT ATMOSPHERE BASF SE (DE) 2023-05-31 EP claimed
EP-4185626-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-05-31 EP claimed
CN-116134063-A Application of ring opening of uretdione at low temperature and normal pressure 巴斯夫欧洲公司 2023-05-16 CN claimed
WO-2022018213-A1 APPLICATION OF THE RING-OPENING OF URETDIONES AT LOW TEMPERATURE AND AMBIENT ATMOSPHERE BASF SE (DE) 2022-01-27 WO claimed
US-12617892-B2 Application of the ring-opening of uretdiones at low temperature and ambient atmosphere BASF SE (DE) 2026-05-05 US disclosed
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BASF SE (DE) 2025-12-30 US disclosed
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BASF SE (DE) 2025-12-30 US disclosed
US-20230348657-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-11-02 US disclosed
US-20230348657-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-11-02 US disclosed
US-20230323013-A1 APPLICATION OF THE RING-OPENING OF URETDIONES AT LOW TEMPERATURE AND AMBIENT ATMOSPHERE BASF SE (DE) 2023-10-12 US disclosed
EP-4185627-A1 APPLICATION OF THE RING-OPENING OF URETDIONES AT LOW TEMPERATURE AND AMBIENT ATMOSPHERE BASF SE (DE) 2023-05-31 EP disclosed
EP-4185626-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-05-31 EP disclosed
CN-116137864-A Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component 巴斯夫欧洲公司 2023-05-19 CN disclosed
CN-116134063-A Application of ring opening of uretdione at low temperature and normal pressure 巴斯夫欧洲公司 2023-05-16 CN disclosed
WO-2023046704-A1 ELECTROCHEMICAL GAS SENSOR AND ELECTROLYTE FOR AN ELECTROCHEMICAL GAS SENSOR Dräger Safety AG & Co. KGaA (DE) 2023-03-30 WO disclosed
WO-2022018213-A1 APPLICATION OF THE RING-OPENING OF URETDIONES AT LOW TEMPERATURE AND AMBIENT ATMOSPHERE BASF SE (DE) 2022-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617892-B2 Application of the ring-opening of uretdiones at low temperature and ambient atmosphere UQCRB, SCO2, UTS2R BBOX1 1545/4885LMNA 108/4885APOBEC3A 2434/4885
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BMP1, BMP4, PBRM1 BBOX1 830/4885LMNA 163/4885APOBEC3A 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.